Coeptis therapeutics' chief scientific and medical officer to present at upcoming fall conferences, highlighting progress in universal cell therapy

Wexford, pa. , oct. 15, 2024 /prnewswire/ -- coeptis therapeutics holdings, inc. (nasdaq: coep) (the "company" or "coeptis"), a biopharmaceutical company developing innovative cell therapy platforms for cancer, autoimmune, and infectious diseases, announced that its chief scientific and medical officer colleen delaney, md will attend and present at the following upcoming fall conferences.
UVV Ratings Summary
UVV Quant Ranking